These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 7847563
1. The action of two natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide) in the human placental vasculature. Holcberg G, Kossenjans W, Brewer A, Miodovnik M, Myatt L. Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):71-7. PubMed ID: 7847563 [Abstract] [Full Text] [Related]
2. Selective vasodilator effects of atrial natriuretic peptide in the human placental vasculature. Holcberg G, Kossenjans W, Brewer A, Miodovnik M, Myatt L. J Soc Gynecol Investig; 1995 Jan; 2(1):1-5. PubMed ID: 9420840 [Abstract] [Full Text] [Related]
3. Interaction of angiotensin II and brain natriuretic peptide in the placentas of normal and diabetic women. Holcberg G, Miodovnik M, Rosenn B, Kossenjans W, Myatt L. Obstet Gynecol; 1995 Mar; 85(3):428-32. PubMed ID: 7862385 [Abstract] [Full Text] [Related]
4. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Myatt L, Brewer AS, Langdon G, Brockman DE. Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):224-30. PubMed ID: 1733199 [Abstract] [Full Text] [Related]
5. The effects of atrial natriuretic factor and angiotensin II on fetal-placental perfusion pressure in the ex vivo cotyledon model. Markenson GR, Foley K, Maslow AS, Kopelman JN. Am J Obstet Gynecol; 1995 Oct; 173(4):1143-7. PubMed ID: 7485308 [Abstract] [Full Text] [Related]
6. Alpha-atrial natriuretic peptide-induced attenuation of vasoconstriction in the fetal circulation of the human isolated perfused placenta. Stebbing PN, Gude NM, King RG, Brennecke SP. J Perinat Med; 1996 Oct; 24(3):253-60. PubMed ID: 8827574 [Abstract] [Full Text] [Related]
7. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature. Wieczorek KM, Brewer AS, Myatt L. Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):708-13. PubMed ID: 7573230 [Abstract] [Full Text] [Related]
8. Interaction of angiotensin II and atrial natriuretic peptide in the human fetoplacental unit. McQueen J, Jardine A, Kingdom J, Templeton A, Whittle MJ, Connell JM. Am J Hypertens; 1990 Aug; 3(8 Pt 1):641-4. PubMed ID: 2171565 [Abstract] [Full Text] [Related]
9. The interaction of nitric oxide and superoxide in the human fetal-placental vasculature. Holcberg G, Kossenjans W, Miodovnik M, Myatt L. Am J Obstet Gynecol; 1995 Aug; 173(2):528-33. PubMed ID: 7544069 [Abstract] [Full Text] [Related]
10. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man. Cargill RI, Struthers AD, Lipworth BJ. Clin Sci (Lond); 1995 Jan; 88(1):81-6. PubMed ID: 7705006 [Abstract] [Full Text] [Related]
11. Role of nitric oxide on cardiac hormone secretion: effect of NG-nitro-L-arginine methyl ester on atrial natriuretic peptide and brain natriuretic peptide release. Leskinen H, Vuolteenaho O, Leppäluoto J, Ruskoaho H. Endocrinology; 1995 Mar; 136(3):1241-9. PubMed ID: 7867578 [Abstract] [Full Text] [Related]
12. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation. Leitch IM, Read MA, Boura AL, Walters WA. Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):615-22. PubMed ID: 7529152 [Abstract] [Full Text] [Related]
13. Selective vasodilator effect of magnesium sulfate in human placenta. Holcberg G, Sapir O, Hallak M, Alaa A, Shorok HY, David Y, Katz M, Huleihel M. Am J Reprod Immunol; 2004 Mar; 51(3):192-7. PubMed ID: 15209387 [Abstract] [Full Text] [Related]
16. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart. Bauer WR, Neubauer S, Obitz G, Ertl G. J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008 [Abstract] [Full Text] [Related]
17. Vasodilatory response of fetoplacental vasculature to adrenomedullin after constriction with the thromboxane sympathomimetic U46619. Hoeldtke NJ, Wagner RK, Calhoun BC, Hume RF. Am J Obstet Gynecol; 2000 Dec; 183(6):1573-8. PubMed ID: 11120530 [Abstract] [Full Text] [Related]
18. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro. Roe CM, Leitch IM, Boura AL, Smith R. J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301 [Abstract] [Full Text] [Related]
19. L-arginine prevents hypoxia-induced vasoconstriction in dual-perfused human placental cotyledons. Bednov A, Espinoza J, Betancourt A, Vedernikov Y, Belfort M, Yallampalli C. Placenta; 2015 Nov; 36(11):1254-9. PubMed ID: 26342955 [Abstract] [Full Text] [Related]
20. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats. Reis WL, Giusti-Paiva A, Ventura RR, Margatho LO, Gomes DA, Elias LL, Antunes-Rodrigues J. Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344 [Abstract] [Full Text] [Related] Page: [Next] [New Search]